M. Deseyve

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

Dorothy Bray, Paul Bakaki, L. Mofenson, 1999, The Lancet.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow up of the HIVNET 012 randomized trial

L. Mofenson, M. Fowler, P. Musoke, 2004 .

Mortality Among HIV-1-Infected Women According to Children's Feeding Modality: An Individual Patient Data Meta-Analysis

Leroy, W. Willett, W. Fawzi, 2005, Journal of acquired immune deficiency syndromes.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

Dorothy Bray, Paul Bakaki, L. Mofenson, 2003, The Lancet.

Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).

P. Musoke, L. Guay, J. Jackson, 2001, The Journal of infectious diseases.

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)

L. Mofenson, M. Fowler, P. Musoke, 2001, AIDS.